APA

Bullement A., Meng Y., Cooper M., Lee D., Harding T. L., O'Regan C. & Aguiar-Ibanez R. (20190617). A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?. : Journal of medical economics.

Chicago

Bullement Ash, Meng Yang, Cooper Miranda, Lee Dawn, Harding Tara Louise, O'Regan Chris and Aguiar-Ibanez Raquel. 20190617. A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?. : Journal of medical economics.

Harvard

Bullement A., Meng Y., Cooper M., Lee D., Harding T. L., O'Regan C. and Aguiar-Ibanez R. (20190617). A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?. : Journal of medical economics.

MLA

Bullement Ash, Meng Yang, Cooper Miranda, Lee Dawn, Harding Tara Louise, O'Regan Chris and Aguiar-Ibanez Raquel. A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?. : Journal of medical economics. 20190617.